Elmind Capital »

Legend Biotech 2 Adr Rep Ord shares owned by Elmind Capital

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $17M 571k 28.88

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Relay Therapeutics (RLAY)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
Pharvaris N V (PHVS)
Miragen Therapeutics (VRDN)
Cytomx Therapeutics (CTMX)
Travere Therapeutics (TVTX)
Legend Biotech Corp Sponsored Ads (LEGN)
Beam Therapeutics (BEAM)
Cullinan Oncology (CGEM)
Nurix Therapeutics (NRIX)
Krystal Biotech (KRYS)

View all positions for Elmind Capital

Top funds holding Legend Biotech 2 Adr Rep Ord

FMR
Deerfield Management Company
Suvretta Capital Management
Hillhouse Capital Advisors
BlackRock
Westfield Capital Management Company
Goldman Sachs Group
Point72 Asset Management
First Beijing Investment
Assenagon Asset Management
Kynam Capital Management
Artisan Partners Limited Partnership
State Street Corporation
Davern Capital Partners
Soleus Capital Management

View all funds holding Legend Biotech 2 Adr Rep Ord